MEGAN KEHRIG: Open Payments
NPI 1932854502 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,041 in 139 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $2,267 · 2025 $3,041
Food & beverage: $2,861Education: $180
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $570 |
| Regeneron Healthcare Solutions, Inc. | 17 | $437 |
| ABBVIE INC. | 23 | $348 |
| UCB, Inc. | 12 | $295 |
| Novartis Pharmaceuticals Corporation | 21 | $222 |
| Janssen Biotech, Inc. | 10 | $192 |
| LEO Pharma Inc. | 17 | $176 |
| Organon LLC | 4 | $171 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, TREMFYA, COSENTYX, Leqselvi, VTAMA, ANZUPGO.
Industry payments across MI — which companies pay providers there.
